New immunologically non-specific immunosuppressive agents dictate changes in standard protocols for renal transplant management.
Helderman
J H
JH
Vanderbilt Transplant Center, Nashville, TN, USA.
D002985:Clinical Protocols; D006084:Graft Rejection / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation
D007166:Immunosuppressive Agents